Prothena Corp Public Ltd Co (PRTA): Shareholders' Equity
$280.47M
As of 2025-12-31
$286.89M
As of 2026-06-30
-23.3%
3-year compound annual growth
+8.8%
5-year compound annual growth
-2.5%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $280.47M | -42.4% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $486.93M | -13.3% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $561.37M | -9.8% | 2026-02-27, Balance as of period end |
| 2022-12-31 | $622.04M | +33.5% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $466.04M | +153.3% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $184.01M | -32.6% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $272.92M | -15.5% | 2022-02-25, Balance as of period end |
| 2018-12-31 | $323.00M | -20.7% | 2021-02-26, Balance as of period end |
| 2017-12-31 | $407.19M | +11.4% | 2020-03-03, Balance as of period end |
| 2016-12-31 | $365.40M | +1.3% | 2019-03-15, Balance as of period end |
| 2015-12-31 | $360.67M | +24.4% | 2018-02-26, Balance as of period end |
| 2014-12-31 | $289.89M | +67.3% | 2017-02-27, Balance as of period end |
| 2013-12-31 | $173.27M | +37.0% | 2016-02-25, Balance as of period end |
| 2012-12-31 | $126.48M | n/m | 2015-03-13, Balance as of period end |
| 2011-12-31 | -$6.44M | n/a | 2014-03-07, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | $280.47M | -42.4% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $20.91M | -45.7% |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | $956.82M | -6.4% |
| Zenas BioPharma, Inc. (ZBIO) | 2025-12-31 | $242.14M | -22.5% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$4.06M | n/m |
| BioAge Labs, Inc. (BIOA) | 2025-12-31 | $272.05M | -15.8% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $203.01M | n/m |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | $4.53B | -3.4% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | -$18.69M | n/m |
Compare PRTA, PGEN, JANX, ZBIO side by side · Screen every company in Pharmaceutical Preparations ↗